ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ZEPP vs XNDU // EV/EBITDA & P/E VALUATION

Zepp Health Corporation each representing sixteen (Class A) (NYSE) VS. Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ) • 15-METRIC TALLY: ZEPP 0 — XNDU 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZEPP VS. XNDU) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ZEPP XNDU SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 38.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -14.70% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -11.30% — — TIE /operating-margins <GO>
Net Profit Margin -15.50% — — TIE /net-margins <GO>
Revenue Growth (YoY) 41.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.33 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 11.4 30.3 -18.89 XNDU /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $33.0M $946.1M -$913.1M XNDU /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ZEPP REV XNDU REV ZEPP GROSS % XNDU GROSS % ZEPP FCF XNDU FCF
FY 2025 $258.9M $0 38.3% — -$26.2M —
FY 2024 $182.6M — 38.5% — -$25.8M —
FY 2023 $352.9M — — — $42.6M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZEPP // BETA —
XNDU // BETA —